Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award

Published on by Top Pharmaceutical

Dr. Sarah Eliuth Ochoa Hugo | Nanomedicine | Young Scientist Award

Dr. Sarah Eliuth Ochoa Hugo at Center of Research and Assistance in Technology and Design of the State of Jalisco| Mexico

Dr. Sarah Eliuth Ochoa Hugo is a dedicated pharmaceutical chemist, biotechnologist, and researcher specializing in medical and pharmaceutical innovation. Currently pursuing her Ph.D. in Biotechnological Innovation Applied to Health at CIATEJ, she integrates her expertise in biotechnology, nanotechnology, and pharmacology to address critical challenges in cancer, Alzheimer’s disease, and medical device safety. As a lecturer at Universidad del Valle de México, she mentors future health professionals, guiding them in scientific research and publication. Alongside academia, she engages in entrepreneurial initiatives that merge scientific innovation with social impact, demonstrating her commitment to advancing healthcare through research, education, and applied technology.

Publication Profile 

Orcid

Education 

Dr. Sarah Eliuth Ochoa Hugo is currently a Ph.D. candidate in Biotechnological Innovation Applied to Health at CIATEJ, focusing on advanced biomedical solutions. She previously earned her Master of Science in Biotechnological Innovation Applied to Medical and Pharmaceutical Sciences at CIATEJ, where her thesis explored exosomal cargo in Alzheimer’s pathogenesis. Her academic foundation was built at Universidad del Valle de México, where she completed a Bachelor of Science in Pharmaceutical Chemistry and Biotechnology. There, she validated a 3D glioblastoma multiforme culture model. Complementing her degrees, she has completed certifications in pharmaceutical regulation, medical English, cancer biology, pharmacology, and advanced English proficiency.

Experience 

Dr. Sarah Eliuth Ochoa Hugo serves as an undergraduate lecturer in Health Sciences at Universidad del Valle de México, where she promotes research-oriented learning and student publications. She is co-founder of Quality Approvers, a startup advancing process optimization using Lean and Six Sigma methodologies. Previously, she worked as a Pharmaceutical Chemist and Assistant Sanitary Responsible at San Javier Hospital, ensuring pharmaceutical compliance and safety. During the pandemic, she launched Paihuenk, a social entrepreneurship project producing artisanal cosmetics to support local communities. With extensive academic and industry experience, she bridges biomedical research, pharmaceutical practice, and innovation-driven entrepreneurship in health and biotechnology.

Awards and Honors 

Dr. Sarah Eliuth Ochoa Hugo achievements are reflected through her strong academic and research portfolio, including international presentations at the Society for Neuroscience meetings in San Diego and publications in prominent journals. Her certification by COFEPRIS in pharmaceutical dispensing underscores her compliance with industry standards, while academic training from King’s College London, Monash University, and Johns Hopkins has expanded her global expertise. At Universidad del Valle de México, she has been recognized for her excellence in teaching, demonstrated. Her contributions to translational research and community-focused entrepreneurship highlight her growing academic influence.

Research Focus 

Dr. Sarah Eliuth Ochoa Hugo research focuses on cancer therapy, Alzheimer’s disease, and medical device vigilance through biotechnological innovation. She has explored 3D glioblastoma culture models, evaluated phenolic compounds for anticancer activity, and investigated exosomal cargo in Alzheimer’s disease. Her recent work integrates nanotechnology, particularly gold nanostructures, for photothermal therapies in colon cancer. Additionally, she contributes to medical device monitoring and pharmaceutical safety through technovigilance research. Her multidisciplinary approach combines molecular biology, pharmacology, and nanomedicine, aiming to design innovative therapies with clinical applications. By integrating biotechnology with applied health sciences, her work advances precision medicine, preventive care, and translational biomedical innovation.

Publication Top Notes

SooHo Yeo | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

SooHo Yeo | Nanomedicine | Best Researcher Award

Dr SooHo Yeo, College of Pharmacy & Yonsei Institute of Pharmaceutical Sciences, Yonsei University, South Korea

Dr. SooHo Yeo is a research professor at Yonsei University, specializing in pharmaceutics, cosmeceutics, and photodynamic therapy. He holds a Ph.D. in pharmacy from Chung-Ang University, where he focused on artificial skin formulations for topical delivery of adenosine. Dr. Yeo’s research interests include nano/micro-particles, skin absorption, and pharmacokinetic/pharmacodynamic analysis, with applications in cancer treatment and cosmetic clinical tests. He has published numerous studies on nanoparticle-based cancer therapies and anti-adhesive agents. His work contributes significantly to skin irritation, absorption studies, and enhancing anticancer therapies. 🧴💡🔬📚🎓

Publication Profile

Scopus

Education

Dr. SooHo Yeo is a distinguished scholar in the field of pharmacy, having completed his M.S./Ph.D. at the College of Pharmacy, Chung-Ang University, Seoul, Korea, in 2021. His research focused on developing innovative solutions for drug delivery, with his dissertation titled “Artificial Skin Formulation for Topical Delivery of Adenosine.” 🌱💊 His work combines pharmaceutical science and cutting-edge technology to enhance therapeutic efficacy through topical applications. Dr. Yeo’s contributions aim to revolutionize treatments by improving the delivery mechanisms of crucial compounds like adenosine, benefiting patients worldwide. 🧴🌏

Experience

Dr. SooHo Yeo is a dedicated researcher with extensive experience in the field of pharmacy and nanoscience. Since 2023, he has been a Research Professor at the College of Pharmacy, Yonsei University, Incheon, Korea. Prior to this, he served as a Research Professor at the Department of Nanoscience and Engineering, INJE University, Gimhae, Korea, from 2021 to 2023. With a strong focus on advancing research in these fields, Dr. Yeo has made significant contributions to the scientific community. 🔬📚💉🌱

Research Fields

Dr. SooHo Yeo specializes in pharmaceutics and cosmeceutics, focusing on nano/micro-particles, solid dispersion, emulsions, liposomes, films, creams, and inhalers. His research integrates biology and toxicology, including in vitro skin irritation and absorption studies, using cells and reconstructed human epidermis tissues (following OECD guidelines), along with cellular uptake observed through confocal microscopy. Dr. Yeo also conducts pharmacokinetic and pharmacodynamic analysis for anti-cancer and anti-adhesive agents. His cosmetic clinical tests include skin wrinkle and moisture assessments. Additionally, he explores photodynamic therapy, advancing treatments for skin care and cancer therapies. 💉🧴🧬🔬💆‍♀️

Research Focus

Dr. SooHo Yeo’s research primarily focuses on nanotechnology for cancer treatment, particularly in the development of advanced drug delivery systems. His work involves the use of nanoparticles, such as PLGA and solid lipid nanoparticles, to enhance the efficacy of photodynamic therapy (PDT) and chemotherapy. Through innovative drug encapsulation methods, including for agents like Purpurin-18-N-hydroxylimide methyl ester, Dr. Yeo aims to improve therapeutic outcomes in cancer treatment. His studies also explore the use of smart nanoparticles for targeting specific organelles like mitochondria or lysosomes to optimize treatment precision and minimize side effects. 🧬💉🔬💊

Publication Top Notes

Application of PLGA nanoparticles to photodynamic cancer therapy by encapsulating Purpurin-18-N-hydroxylimide methyl ester

4-Hexylresorcinol Loaded Solid Lipid Nanoparticles for Enhancing Anticancer Activity

Enhanced Photodynamic Therapy Efficacy through Solid Lipid Nanoparticle of Purpurin-18-N-Propylimide Methyl Ester for Cancer Treatment

Polysaccharide-based emulsion gels for the prevention of postoperative adhesions and as a drug delivery system using 5-fluorouracil

Design of smart chemotherapy of doxorubicin hydrochloride using nanostructured lipid carriers and solid lipid nanoparticles for improved anticancer efficacy

Long-wavelength absorbing and mitochondria or lysosome organelle-targeting photosensitizers with flexible or rigid terminus for fluorescence imaging and high-performance photodynamic therapy

Improved anticancer efficacy of methyl pyropheophorbide-a–incorporated solid lipid nanoparticles in photodynamic therapy

Transition metal-dependent heavy-atom effect of metallochlorin photosensitizers for enhanced photodynamic therapy

pH-Responsive Nano-transferosomes of Purpurin-18 Sodium Salt and Doxorubicin for Enhanced Anticancer Efficiency by Photodynamic and Chemo Combination Therapy

Long-Wavelength Absorbing Benzimidazolo-Chlorin for Enhanced Photodynamic Therapy